1 - 25 of
48
results
for author:"Dolan M."
in Literature Citations
| Reply to: "Experimental aspects of copy number variant assays at CCL3L1". He W., Kulkarni H., Castiblanco J., Shimizu C., Aluyen U., Maldonado R., Carrillo A., Griffin M., Lipsitt A., Beachy L. et al. Nat. Med. 15:1117-1120(2009) · Mapped (1) |
| The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry. Kulkarni H., Marconi V.C., He W., Landrum M.L., Okulicz J.F., Delmar J., Kazandjian D., Castiblanco J., Ahuja S.S., Wright E.J. et al. Blood 114:2783-2792(2009) · Mapped (12) |
| Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression. Camargo J.F., Kulkarni H., Agan B.K., Gaitan A.A., Beachy L.A., Srinivas S., He W., Anderson S., Marconi V.C., Dolan M.J. et al. J. Infect. Dis. 199:1872-1882(2009) · Mapped (10) |
| Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. Innocenti F., Kroetz D.L., Schuetz E., Dolan M.E., Ramirez J., Relling M., Chen P., Das S., Rosner G.L., Ratain M.J. J. Clin. Oncol. 27:2604-2614(2009) · Mapped (79) |
| Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children. Shostakovich-Koretskaya L., Catano G., Chykarenko Z.A., He W., Gornalusse G., Mummidi S., Sanchez R., Dolan M.J., Ahuja S.S., Clark R.A. et al. AIDS 23:679-688(2009) · Mapped (4) |
| Identification of genomic regions contributing to etoposide-induced cytotoxicity. Bleibel W.K., Duan S., Huang R.S., Kistner E.O., Shukla S.J., Wu X., Badner J.A., Dolan M.E. Hum. Genet. 125:173-180(2009) · UniProtKB (1) |
| Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy. Kulkarni H., Marconi V.C., Agan B.K., McArthur C., Crawford G., Clark R.A., Dolan M.J., Ahuja S.K. PLoS ONE 3:e3671-e3671(2008) · Mapped (24) |
| HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. Catano G., Kulkarni H., He W., Marconi V.C., Agan B.K., Landrum M., Anderson S., Delmar J., Telles V., Song L. et al. PLoS ONE 3:e3636-e3636(2008) · Mapped (2,356) |
| Population-specific GSTM1 copy number variation. Huang R.S., Chen P., Wisel S., Duan S., Zhang W., Cook E.H., Das S., Cox N.J., Dolan M.E. Hum. Mol. Genet. 18:366-372(2009) · Mapped (2) |
| CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals. Kulkarni H., Agan B.K., Marconi V.C., O'Connell R.J., Camargo J.F., He W., Delmar J., Phelps K.R., Crawford G., Clark R.A. et al. PLoS ONE 3:e3165-e3165(2008) · Mapped (24) |
| The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds. Innocenti F., Mirkov S., Nagasubramanian R., Ramirez J., Liu W., Bleibel W.K., Shukla S.J., Hennessy K., Rosner G.L., Cook E. Jr. et al. Cancer Chemother. Pharmacol. 63:881-887(2009) · Mapped (2) |
| Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. He W., Neil S., Kulkarni H., Wright E., Agan B.K., Marconi V.C., Dolan M.J., Weiss R.A., Ahuja S.K. Cell Host Microbe 4:52-62(2008) · Mapped (12) |
| Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Burt T.D., Agan B.K., Marconi V.C., He W., Kulkarni H., Mold J.E., Cavrois M., Huang Y., Mahley R.W., Dolan M.J. et al. Proc. Natl. Acad. Sci. U.S.A. 105:8718-8723(2008) · Mapped (5) |
| Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations. Catano G., Agan B.K., Kulkarni H., Telles V., Marconi V.C., Dolan M.J., Ahuja S.K. J. Infect. Dis. 198:72-80(2008) · Mapped (27) |
| Identification of genetic variants and gene expression relationships associated with pharmacogenes in humans. Huang R.S., Duan S., Kistner E.O., Zhang W., Bleibel W.K., Cox N.J., Dolan M.E. Pharmacogenet. Genomics 18:545-549(2008) · Mapped (10) |
| Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposure. Nagasubramanian R., Hansen R.J., Delaney S.M., Cherian M.M., Samson L.D., Kogan S.C., Dolan M.E. Mutagenesis 23:341-346(2008) · Mapped (5) |
| A novel polymorphism in the FMR1 gene: implications for clinical testing of fragile X syndrome. Thyagarajan B., Bower M., Berger M., Jones S., Dolan M., Wang X. Arch. Pathol. Lab. Med. 132:95-98(2008) · Mapped (6) |
| Crystallographic study of hydration of an internal cavity in engineered proteins with buried polar or ionizable groups. Schlessman J.L., Abe C., Gittis A., Karp D.A., Dolan M.A., Garcia-Moreno E B. Biophys. J. 94:3208-3216(2008) · Mapped (4) |
| CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Dolan M.J., Kulkarni H., Camargo J.F., He W., Smith A., Anaya J.M., Miura T., Hecht F.M., Mamtani M., Pereyra F. et al. Nat. Immunol. 8:1324-1336(2007) · Mapped (24) |
| Conformational effects of a common codon 399 polymorphism on the BRCT1 domain of the XRCC1 protein. Monaco R., Rosal R., Dolan M.A., Pincus M.R., Brandt-Rauf P.W. Protein J. 26:541-546(2007) · Mapped (5) |
| Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding. Yamini B., Yu X., Dolan M.E., Wu M.H., Darga T.E., Kufe D.W., Weichselbaum R.R. Cancer Res. 67:6889-6898(2007) · Mapped (3) |
| Production and secretion of resveratrol in hairy root cultures of peanut. Medina-Bolivar F., Condori J., Rimando A.M., Hubstenberger J., Shelton K., O'Keefe S.F., Bennett S., Dolan M.C. Phytochemistry 68:1992-2003(2007) · UniProtKB (2) |
| The genomic dynamics and evolutionary mechanism of the Pi2/9 locus in rice. Zhou B., Dolan M., Sakai H., Wang G.L. Mol. Plant Microbe Interact. 20:63-71(2007) · UniProtKB (9) |
| Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice. Hansen R.J., Nagasubramanian R., Delaney S.M., Samson L.D., Dolan M.E. Carcinogenesis 28:1111-1116(2007) · Mapped (1) |
| The eight amino-acid differences within three leucine-rich repeats between Pi2 and Piz-t resistance proteins determine the resistance specificity to Magnaporthe grisea. Zhou B., Qu S., Liu G., Dolan M., Sakai H., Lu G., Bellizzi M., Wang G.L. Mol. Plant Microbe Interact. 19:1216-1228(2006) · UniProtKB (12) |
